/Lists

Biotech Investors & VC Firms in North America

1590 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

8VC
AustinPre-Seed–Growth$500K – $50M
64 people
DCVC (Data Collective)
Palo AltoPre-Seed–Growth$5M – $25M
49 people
Draper Associates
San MateoPre-Seed–Series A$500K – $5M
18 people
OrbiMed
New YorkSeed–Late Stage$1M – $75M
92 people
Menlo Ventures
San FranciscoPre-Seed–Late Stage$1M – $20M
44 people
Canaan Partners
StamfordPre-Seed–Series A$500K – $20M
31 people
Founders Fund
San FranciscoSeed–Late Stage$500K – $5M
31 people
B Capital Group
San FranciscoPre-Seed–Late Stage$10M – $50M
94 people
BDC Venture Capital
MontrealPre-Seed–Late Stage$365K – $25.6M
147 people
Madrona Venture Group
SeattlePre-Seed–Growth$2M – $10M
61 people
Summit Partners
BostonSeries B–Growth$10M – $500M
111 people
Creative Destruction Lab (CDL)
TorontoPre-Seed–Series A$50K – $250K
38 people
Cerberus Capital Management
New YorkPre-Seed–Seed
162 people
True Ventures
San FranciscoPre-Seed–Series A$500K – $3M
38 people
Atlas Venture
CambridgeSeed–Late Stage$500K – $1M
108 people
Venrock
Palo AltoSeed–Late Stage$500K – $10M
64 people
Elevate Ventures
IndianapolisPre-Seed–Series A$20K – $2M
22 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
99 people
Saints Capital
San FranciscoGrowth–Late Stage
18 people
Capria Ventures
SeattleSeed–Growth$300K – $1M
19 people
VU Venture Partners
San FranciscoSeed–Series B$200K – $1M
113 people
Lux Capital
New YorkPre-Seed–Growth$100K – $100M
40 people
Lerer Hippeau
New YorkSeed–Series B$500K – $2M
20 people
Connecticut Innovations
New HavenPre-Seed–Growth$500K – $2M
35 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.